Table 6 Average posteriors of individual-level coefficients and relative treatment effects by health status
All | No chronic health condition | Chronic health condition | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Treatment 1 | Treatment 2 | Treatment 1 | Treatment 2 | Treatment 1 | Treatment 2 | |||||
Model B (alternative to status quo) | -1.587 | -1.405 | -1.865 | |||||||
+ 9.3% | + 19.6% | + 8.6% | + 22.0% | + 9.7% | + 17.8% | |||||
(2.4%) | (2.5%) | (3.6%) | (3.6%) | (3.1%) | (3.3%) | |||||
VBID elements | ||||||||||
Copayment | 0% high-value care | 0.570 | 0.473 | 0.719 | ||||||
-44.2% | -44.1% | -44.0 | -44.3% | -44.3% | -44.1% | |||||
(1.2%) | (0.8%) | (1.5%) | (1.2%) | (1.8%) | (1.3%) | |||||
20% low-value care | -0.982 | -0.929 | -1.068 | |||||||
-30.6 | -31.5% | -31.9% | -29.5% | -28.3 | -33.2% | |||||
(2.7%) | (3.0%) | (3.9%) | (4.2%) | (3.7%) | (4.1%) | |||||
Drug disbursement based on value | -0.909 | -0.891 | -0.933 | |||||||
+ 21.8% | + 17.7% | + 21.8% | + 16.7% | + 21.7% | + 19.0% | |||||
(0.8%) | (0.7%) | (1.0%) | (0.9%) | (1.2%) | (1.0%) | |||||
General cost-sharing | ||||||||||
Deductible | CHF 0 | 1.178 | 1.096 | 1.233 | ||||||
-20.6% | -1.3% | -20.9% | -2.2% | -20.1% | + 0.1% | |||||
(1.8%) | (1.8%) | (2.3%) | (2.3%) | (3.0%) | (3.0%) | |||||
CHF 5000 | -4.178 | -4.090 | -4.317 | |||||||
+ 0.0 | -16.6% | + 0.1 | -16.3% | -0.1 | -17.3% | |||||
(1.1%) | (1.3%) | (1.7%) | (1.8%) | (1.6%) | (1.7%) | |||||
Monthly premium | -0.034 | -0.036 | -0.032 | |||||||
-2.8 | -3.4% | -4.4% | -3.4% | -1.3 | -3.3% | |||||
(1.9%) | (1.9%) | (2.7%) | (2.6%) | (2.6%) | (2.7%) | |||||